MedX Health Corp (TSXV:MDX)
0.0600
+0.0050 (9.09%)
At close: Feb 9, 2026
MedX Health Revenue
MedX Health had revenue of 135.27K CAD in the quarter ending September 30, 2025, with 49.29% growth. This brings the company's revenue in the last twelve months to 522.91K, up 42.10% year-over-year. In the year 2024, MedX Health had annual revenue of 489.70K with 7.37% growth.
Revenue (ttm)
522.91K
Revenue Growth
+42.10%
P/S Ratio
37.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 489.70K | 33.61K | 7.37% |
| Dec 31, 2023 | 456.09K | -54.52K | -10.68% |
| Dec 31, 2022 | 510.61K | -52.50K | -9.32% |
| Dec 31, 2021 | 563.10K | 33.04K | 6.23% |
| Dec 31, 2020 | 530.07K | -330.18K | -38.38% |
| Dec 31, 2019 | 860.25K | -227.18K | -20.89% |
| Dec 31, 2018 | 1.09M | -5.81K | -0.53% |
| Dec 31, 2017 | 1.09M | 276.18K | 33.80% |
| Dec 31, 2016 | 817.06K | -354.37K | -30.25% |
| Dec 31, 2015 | 1.17M | 293.69K | 33.46% |
| Dec 31, 2014 | 877.73K | 298.09K | 51.43% |
| Dec 31, 2013 | 579.65K | -148.64K | -20.41% |
| Dec 31, 2012 | 728.29K | -144.30K | -16.54% |
| Dec 31, 2011 | 872.58K | 215.23K | 32.74% |
| Dec 31, 2010 | 657.36K | 205.98K | 45.63% |
| Dec 31, 2009 | 451.38K | -698.10K | -60.73% |
| Dec 31, 2008 | 1.15M | 93.69K | 8.87% |
| Dec 31, 2007 | 1.06M | -1.54M | -59.34% |
| Dec 31, 2006 | 2.60M | -335.74K | -11.45% |
| Dec 31, 2005 | 2.93M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 25.14M |
| Conavi Medical | 9.12M |
| Perimeter Medical Imaging AI | 2.78M |
| Cheelcare | 1.56M |
| Frequency Exchange | 1.12M |
| Theralase Technologies | 1.00M |
| NuGen Medical Devices | 589.43K |
| Ventripoint Diagnostics | 175.62K |
MedX Health News
- 7 days ago - MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes - Business Wire
- 12 days ago - Original-Research: MedX Health Corp (von First Berlin Equity Research GmbH): BUY • news - Onvista
- 2 months ago - MedX Health 2025 YEAR REVIEW - Business Wire
- 3 months ago - MedX Announces Final Closing of Non-Brokered Private Placement - Business Wire
- 4 months ago - MedX announces Initial Closing and Proposed Extension of Non-Brokered Private Placement - Business Wire
- 4 months ago - MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development - Business Wire
- 5 months ago - MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Business Wire
- 5 months ago - MedX Announces Proposed Extension of Non-Brokered Private Placement - Business Wire